Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers - PubMed (original) (raw)

Comparative Study

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers

K Y Shin et al. Br J Cancer. 1997.

Free PMC article

Abstract

Cyclin D1 is a cell cycle regulator essential for G1 phase progression and is frequently overexpressed in several human tumour types as a consequence of gene amplification or chromosomal rearrangements. We analysed the expression of cyclin D1 in 75 patients with transitional cell carcinoma (TCC) to investigate the possible relationship between its expression and clinical outcome as well as histopathological findings using the immunohistochemical method. We observed strong staining (++, > 50% positive cells) for cyclin D1 in 19 cases (25.3%) and weak staining (+, 5-50% positive cells) in 19 cases (25.3%). Overexpression of cyclin D1 was not associated with tumour invasion. No significant association was found between overexpression of cyclin D1 and tumour grade (P > 0.05). We assessed the differences of disease-free interval in superficial tumours and actuarial survival probability in invasive tumours according to the status of cyclin D1 expression. Tumours with (++) staining for cyclin D1 recurred much more rapidly than (-) and/or (+) staining tumours (P < 0.01 for - vs ++; P < 0.05 for + vs ++). However, overexpression of cyclin D1 was not associated with a shortened overall survival of patients with invasive tumours (P < 0.1). These results suggest that genetic alteration of cyclin D1 appears to be an early event in the tumorigenesis of bladder TCC and is associated with early recurrence in superficial tumours.

PubMed Disclaimer

Cited by

Understanding molecular markers in recurrent oral squamous cell carcinoma treated with chemoradiation.
Gupta S, Kushwaha VS, Verma S, Khan H, Bhatt ML, Husain N, Negi MP, Bhosale VV, Ghatak A. Gupta S, et al. Heliyon. 2016 Dec 5;2(12):e00206. doi: 10.1016/j.heliyon.2016.e00206. eCollection 2016 Dec. Heliyon. 2016. PMID: 27981249 Free PMC article.
Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands.
de Souza AA, Altemani A, Passador-Santos F, Turssi CP, de Araujo NS, de Araújo VC, Soares AB. de Souza AA, et al. Virchows Arch. 2015 Sep;467(3):295-301. doi: 10.1007/s00428-015-1804-x. Epub 2015 Jul 9. Virchows Arch. 2015. PMID: 26155914
Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM, Braithwaite KL, Angus B, Neal DE, Lunec J, Mellon JK. Tut VM, et al. Br J Cancer. 2001 Jan;84(2):270-5. doi: 10.1054/bjoc.2000.1557. Br J Cancer. 2001. PMID: 11161387 Free PMC article.
Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder.
Khan AA, Abel PD, Chaudhary KS, Gulzar Z, Stamp GW, Lalani EN. Khan AA, et al. Mol Pathol. 2003 Dec;56(6):353-61. doi: 10.1136/mp.56.6.353. Mol Pathol. 2003. PMID: 14645699 Free PMC article.
Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.
Keum JS, Kong G, Yang SC, Shin DH, Park SS, Lee JH, Lee JD. Keum JS, et al. Br J Cancer. 1999 Sep;81(1):127-32. doi: 10.1038/sj.bjc.6690661. Br J Cancer. 1999. PMID: 10487623 Free PMC article.

References

1. Br J Cancer. 1996 Mar;73(6):728-34 - PubMed
1. Gene. 1995 Jun 14;159(1):83-96 - PubMed
1. Br J Cancer. 1977 Jan;35(1):1-39 - PubMed
1. Cell. 1983 Jun;33(2):389-96 - PubMed
1. J Urol. 1983 Dec;130(6):1083-6 - PubMed

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers - PubMed (original) (raw)